Home » Topics » Regulatory » Patents

Patents
RSS

Jiangsu Carefree, Nanjing Carephar and Nanjing Carephar Shenghui report JAK inhibitors

April 8, 2016

Changzhou Yinsheng Pharmaceutical and Sichuan University patent HCV NS4B inhibitors

April 8, 2016

Bayer Schering Pharma divulges factor XIa inhibitors

April 8, 2016

FORMA Therapeutics develops mutant-isocitrate dehydrogenase inhibitors

April 7, 2016

Epizyme presents lysine-specific demethylase inhibitors

April 7, 2016

Ironwood Pharmaceuticals describes sGC activators

April 7, 2016

AbbVie discloses HAT inhibitors

April 7, 2016

Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors

April 7, 2016

Bristol-Myers Squibb patent describes free fatty acid receptor agonists

April 6, 2016

Shire patents dopamine transporter inhibitors

April 6, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...